You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Claims for Patent: 6,121,291


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,121,291
Title: Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder
Abstract:This invention relates to the use of paroxetine or a pharmaceutically acceptable salt thereof for the treatment of post-traumatic stress disorder and depression associated with withdrawal from heroin abuse.
Inventor(s): Gleason; Maurice (Newbury, GB)
Assignee: SmithKline Beecham plc (Brentford, GB)
Application Number:09/142,990
Patent Claims: 1. A method for treating or preventing post traumatic stress disorder, in humans or non-human animals, which method comprises administering an effective amount of paroxetine or a pharmaceutically acceptable salt thereof, to human or non-human animals in need thereof.

2. A method for treating or preventing depression associated with

withdrawal from heroin abuse, in humans or non-human animals, which method comprises administering an effective amount of paroxetine or a pharmaceutically acceptable salt thereof, to human or non-human animals in need thereof.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.